Reneuron Share Discussion Threads

[stewart_25] 20/4/2017 09:22

what is with the video? content? impact on rene?

[deutsch3] 20/4/2017 09:18

Somebody is systematically ditching big lumps. Its been going on for a while. I hope the Bod are not being complicit in their silence!

[stevedd] 20/4/2017 08:22

I haven't heard of this video. Does anybody have a link or an overview of the content?

[fredd1eboy] 19/4/2017 16:56

Reply from Rene to omg iii site....

Here you go Freddie

Thank you for your email and for your support as a shareholder of ReNeuron.

ReNeuron is aware of the video posted on social media and can confirm that the company was not involved in making it or had prior knowledge of its publication.

ReNeuron is the sponsor of the Phase I/II clinical trial in RP, a role in which it provides the drug product and finances the trial but is not directly involved with study participants.

Whilst it isn’t appropriate for ReNeuron to comment on the content of the video, please rest assured that ReNeuron will announce clinical data from the RP study, and other clinical programmes, in a timely manner through the conventional regulatory channel of RNS.

I would make the general point that the results of clinical trials are based on statistical analysis of all patients that complete a trial. A single patient, even in a small study, is not necessarily representative of the overall study results - that could only be known in hindsight. All trials, even late stage ones, have non-responders to the potential treatment being studied.

A further general point on early stage trials is that they are designed to inform later studies by establishing safety, tolerability and frequently dosage. For example, the Phase II part of the current Phase I/II trial in RP will be conducted at the highest safe dose in RP patients with a greater level of vision.

[yachtmaster2] 19/4/2017 13:54

Perphaps it will reach zero. Heading that way

[norbus] 19/4/2017 13:35

Meantime, Mike Hunt takes a fat salary home

[norbus] 18/4/2017 10:56

Shafted again?
Rocket Fuel he says a leopard doth never changeth its spots

[megashareman] 05/4/2017 11:15

Think what hi did with the company before Hope not but is still in my head And still hurts

[norbus] 05/4/2017 09:25

to go lower you mean? What is fair value? Crooked board silent. Always thought Mike Hunt was not steering straight

[bonzo] 04/4/2017 14:13

You need a long time horizon here....!!!

[fredd1eboy] 03/4/2017 17:31

Another early trade....only just reported

Time...... .....Price........Volume........ ...Value
09:03:39......2.144........1,800,000..........£38.59k

[fredd1eboy] 03/4/2017 16:46

Thereby hangs a tale.....

Time...............Price...............Volume ....Value
16:37:21...........2.1469..........1,956,032......£41.99k

[fredd1eboy] 03/4/2017 12:42

I'm particularly interested in the longer term follow-up for Ren001 treated patients which hopefully will improve our chances of FDA phase 3 commencement approvals. As for Ren003/009 I'm really frustrated with the lack of news. Fingers crossed Olavs teasing us and there's plenty of positive activity going on behind the scenes. Best wishes. Freddie

[stewart_25] 03/4/2017 09:58

the share price is bloody ridiculous... not sure even bottom drawer is good enough for rene now....

[fredd1eboy] 31/3/2017 12:55

This time over 13 months ago...

Guildford, UK, 23 February 2016: ReNeuron Group plc (the “Company”;) (AIM: RENE), a leading UK-based stem cell therapy development company, is pleased to announce that, from 29 February 2016, its headquarters, research laboratories and manufacturing facilities will be located at a new purpose-built building on the Pencoed Business Park, just off the M4 motorway at Pencoed, South Wales.

Wonder how the manufacturing licensing is going!!

[fredd1eboy] 31/3/2017 12:50

THIS TIME OVER MONTH 12 MONTHS AGO

Pencoed, UK, 15 March 2016: ReNeuron Group plc (the “Company”;) (AIM: RENE), a leading UK-based stem cell therapy development company, is pleased to announce that the first patient has been treated with the Company’s cell therapy candidate for the blindness-causing disease retinitis pigmentosa (RP) in a first-in-human US clinical trial. The procedure, involving a single injection of hRPC cells under the retina, was conducted at Massachusetts Eye and Ear in Boston, a teaching affiliate of Harvard Medical School (HMS) and a world-renowned clinical and research centre for the treatment of eye disease, including retinal degeneration. The patient was discharged from hospital on the same day.

WONDER HOW THE PATIENT IS DOING!!!!

[norbus] 31/3/2017 11:59

You guys need to kick up a fuss; You are being treated like mushrooms; preparing you for the Institutional theft at 4p ; This company was born in a crooked culture Shafted the Queen who bought 200000 at £2 each. bought back the shares for pennies, floated them again, at 25p and here we are. Hunt did well as did the CTO. Smelled worse than rotten eggs so I departed at 6.5p

[fredd1eboy] 30/3/2017 17:39

Well done yachtmaster. For what it's worth I think you will get you're 10p and realise your dream. Love Astons but with my commitments it will be an xkrs

[yachtmaster2] 30/3/2017 17:16

Was only joking Freddie. 10p would get me my new Vanqiuish S which would be the icing on the start of my early semi retirement next month. Dream on I say. Will buy a few euro millions tickets as well.
Regards

[hlp_4u] 30/3/2017 16:54

Dr Westons Incredible People medical programme on BBC2 last night highlighted miraculous cure for patient with MS...gone from wheelchair to being able to renew his diving certificates 2 years after initial treatment of injecting stem cells into brain

[fredd1eboy] 30/3/2017 14:44

Hi yachtmaster. If they are headed to where you suggest someone's destined to run off with the £50 to £60m they have in the bank. As I don't think any of us believe that will happen, for that reason 'your fired'
Do, however. agree with you about the boring though!!!
So frustrating.
Best wishes.
Freddie

[yachtmaster2] 30/3/2017 13:58

No chance Freddie. Heading to zero. They've bored the market to death!

[fredd1eboy] 30/3/2017 08:31

Hopefully a business update soon and then we will have some facts to enable a meaningful discussion. By the way, I'm as frustrated as the rest of you. Communication, timing and a good PR strategy.....not Rene's strongpoints.
Let's hope they excel at the science and make up for shortfalls!!!!